Answers are grounded in this paper and cite their sources.
Background Extruded or sequestered fragments of lumbar disc herniation (LDH) often regress during conservative care. Neovascularization, macrophage recruitment, phagocytosis, and matrix proteolysis support this clearance, whereas the contribution of nucleus pulposus (NP)-cell death remains uncertain. Main body This narrative review compares regulated NP-cell death in retained-disc degeneration and extruded tissue. Apoptosis, pyroptosis, ferroptosis, necroptosis, and PANoptosis have been implicated in degeneration, but fragment-specific and cell-resolved evidence remains limited. In retained discs, NP-cell loss reduces matrix-maintenance capacity. After extrusion, vascular and immune access may alter how dying cells and their products interact with host clearance. We propose accessibility as a testable modifier of the relationship between NP-cell death and fragment regression. Anatomical compartment serves as a clinical proxy, while local access, cellular composition, microenvironment, and inflammatory timing define the biological context. The framework predicts stronger death–clearance associations within accessible fragment regions and stronger death–regression associations where measured host access is greater. Testing causality requires NP-cell-specific manipulation of a defined death program, confirmation of altered death before regression, and rescue experiments. Intervention effects alone cannot establish death-mediated clearance because inflammatory signaling and direct effects on host cells may independently alter regression. Injury and inflammation could also promote both NP-cell death and host recruitment without death contributing to clearance. Longitudinal imaging can quantify regression, but validating the proposed interaction requires linked tissue measurements and experimental models. Pharmacological studies, including natural products and traditional Chinese medicine, mainly support cytoprotection in retained-disc models. Conclusion Evidence for death-associated fragment clearance remains sparse and indirect. Fragment regression, pain relief, and parent-disc preservation should be assessed separately. The framework is hypothesis-generating and does not support clinical promotion of NP-cell death.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: